Funding Opportunity PAR-20-305 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are derived from the same organ system, such as gastrointestinal, neuroendocrine, head and neck, and other cancers. Other programmatically appropriate groups of cancers may include those centered around a common biological mechanism critical for promoting tumorigenesis and/or cancer progression in organ sites that belong to different organ systems. For example, a SPORE may focus on cancers caused by the same infectious agent or cancers promoted and sustained by dysregulation of a common signaling pathway. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant.

Notice NOT-MD-21-002 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-055 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-001 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-176 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-620 from the NIH Guide for Grants and Contracts. The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Notice NOT-CA-20-108 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-812 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-701 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding Opportunity RFA-HL-21-018 from the NIH Guide for Grants and Contracts. This funding opportunity announcement solicits research project grant (R01) applications that propose to utilize a syndemics (synergistic epidemic) framework to elucidate the role that social, economic, environmental, behavioral, structural, psychological factors play in promoting the synergistic interactions and clustering of heart, lung, blood, and sleep (HLBS) comorbidities and multi-morbidities among people with HIV at the population level. The ultimate goal is to identify strategies that foster integrated and holistic approaches in the clinical management of people living with HIV suffering from HLBS comorbidities and multi-morbidities and to generate useful data to assess the feasibility and cost-effectiveness of such approaches.

Notice NOT-MD-20-028 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-20-055 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research to improve understanding of the evolutionary dynamics of seasonal influenza to increase our capacity to predict the emergence of new antigenic variants and more accurately select strains for use in the seasonal influenza vaccine.

Funding Opportunity RFA-DK-20-505 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application for the Scientific Data Research Center (SDRC) of the Gastroparesis Clinical Research Consortium (GpCRC). The companion FOA, RFA-DK-20-504 will support continuation of the GpCRC Clinical Centers (CC). The Consortium forms a multi-disciplinary teams composed of members from the CCs and SDRC to undertake a comprehensive clinical, epidemiological and biological characterization of adult and children patients with GP to gain insight into the pathophysiology of GP and its sequela: chronic abdominal pain, nausea and vomiting, poor metabolic control and impaired quality of life. To achieve the goal of a comprehensive characterization of evolving Gastroparesis both in diabetic and non-diabetic patients, as well as in children the Scientific Data Research Center (SDRC) will take on the administrative and data collection/analysis functions and will be responsible for the conduct of all of the ongoing and future studies of the CCs In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood stools and when feasible gastric tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection as well as to build on the ongoing Pathological Basis of gastroparesis study which will increase understanding of the pathological basis of gastroparesis.

Notice NOT-HL-20-817 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-038 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-20-504 from the NIH Guide for Grants and Contracts. The primary purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the clinical sites that have participated in the NIDDK Gastroparesis Clinical Research Consortium (GPRCR), to support the ongoing GPCRC cohorts, including the first U.S. registry of children and adolescents with gastroparesis, to support ongoing clinical trials and to provide a platform for informative ancillary studies. In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood stools and when feasible gastric tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection as well as to build on the ongoing Pathological Basis of gastroparesis study which will increase understanding of the pathological basis of gastroparesis.

Notice NOT-MD-20-030 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-312 from the NIH Guide for Grants and Contracts. The primary purpose of this Funding Opportunity Announcement (FOA) is to solicit meritorious applications for the continuity and expansion of existing state occupational safety and health surveillance programs and the development of new programs, with the goal of improving surveillance across the US.

Notice NOT-AG-20-052 from the NIH Guide for Grants and Contracts